TherapeuticsMD, Inc.TherapeuticsMD, Inc.TherapeuticsMD, Inc.

TherapeuticsMD, Inc.

No trades
See on Supercharts
Market capitalization
‪21.45 M‬USD
−1.00USD
‪−10.28 M‬USD
‪1.30 M‬USD
‪11.09 M‬
Beta (1Y)
1.57

About TherapeuticsMD, Inc.

CEO
Marlan D. Walker
Headquarters
Boca Raton
Employees (FY)
1
Founded
1907
ISIN
US88338N2062
FIGI
BBG000LKB954
TherapeuticsMD, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of products for women. The firm's technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. It also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the BIJUVA, IMVEXXY, vitaMedMD and BocaGreenMD brands. The company was founded by Robert G. Finizio and Brian A. Bernick in 1907 and is headquartered in Boca Raton, FL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TXMD is 1.86 USD — it has decreased by 1.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TherapeuticsMD, Inc. stocks are traded under the ticker TXMD.
TherapeuticsMD, Inc. is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
TXMD stock is 6.56% volatile and has beta coefficient of 1.57. Check out the list of the most volatile stocks — is TherapeuticsMD, Inc. there?
TXMD earnings for the last quarter are −0.13 USD per share, whereas the estimation was −0.15 USD resulting in a 13.33% surprise. The estimated earnings for the next quarter are −0.13 USD per share. See more details about TherapeuticsMD, Inc. earnings.
TherapeuticsMD, Inc. revenue for the last quarter amounts to ‪400.00 K‬ USD despite the estimated figure of ‪1.70 M‬ USD. In the next quarter revenue is expected to reach ‪500.00 K‬ USD.
Yes, you can track TherapeuticsMD, Inc. financials in yearly and quarterly reports right on TradingView.
TXMD stock has fallen by 10.58% compared to the previous week, the month change is a 19.83% fall, over the last year TherapeuticsMD, Inc. has showed a 49.73% decrease.
TXMD net income for the last quarter is ‪−883.00 K‬ USD, while the quarter before that showed ‪−3.38 M‬ USD of net income which accounts for 73.86% change. Track more TherapeuticsMD, Inc. financial stats to get the full picture.
Today TherapeuticsMD, Inc. has the market capitalization of ‪21.45 M‬, it has decreased by 3.79% over the last week.
No, TXMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TXMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TherapeuticsMD, Inc. stock right from TradingView charts — choose your broker and connect to your account.
TXMD reached its all-time high on Feb 2, 2010 with the price of 8000.00 USD, and its all-time low was 1.95 USD and was reached on Oct 26, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 1.00 employees. See our rating of the largest employees — is TherapeuticsMD, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TherapeuticsMD, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TherapeuticsMD, Inc. stock shows the sell signal. See more of TherapeuticsMD, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TherapeuticsMD, Inc. EBITDA is ‪−7.60 M‬ USD, and current EBITDA margin is −583.79%. See more stats in TherapeuticsMD, Inc. financial statements.